Jeffrey Rosen and Jeffrey Clark

Hosted by and

Acting Assistant U.S. Attorney General Jeffrey Clark speaks next to Deputy U.S. Attorney General Jeffrey Rosen at a news conference, where they announced that Purdue Pharma LP has agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, at the Justice Department in Washington, U.S., October 21, 2020. Photo by Yuri Gripas/Reuters

Former acting Attorney General Jeffrey Rosen testified about what happened between him, Donald Trump, and former acting head of DOJ Civil Division Jeffrey Clark in a closed session with the DOJ Inspector General and the Senate Judiciary Committee. TL:DR and also it was a closed session, so here’s what we know; Clark tried to pressure former president Trump to remove Rosen and install Clark as acting AG while Trump was trying to get the 2020 election results thrown out. Does this meeting mean Clark could face legal consequences? What about political consequences? We discuss.

Next: A motion to dismiss Dominion’s lawsuits falls flat, and a judge allows the company to pursue a deceptive trade practices suit against MyPillow CEO Mike Lindell, among others. What does that mean for Dominion’s chances of winning damages, and how does a defamation suit work when the defendants believe what they’re saying is true?

Finally: an update on Michael Avenatti. He’s trying to get at least a couple motions for a mistrial and he might be behaving too much like a civil lawyer in a criminal trial.



Sara Fay